RxSight (RXST) Stock Chart & Stock Price History $12.79 +0.36 (+2.90%) Closing price 04:00 PM EasternExtended Trading$8.50 -4.29 (-33.54%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RxSight Stock Price Performance The RxSight (RXST) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 77.58%, with a year-to-date return of -62.86%. In the past month, the stock has decreased 15.09%, reflecting recent market activity. As of the latest close, RxSight traded at $12.43 with a market cap of $530.31 million and volume of 864,320 shares. Receive RXST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.25%1 Month Performance-15.09%3 Month Performance-14.81%Year-To-Date Performance-62.86%1 Year Performance-77.58% RXST Stock Chart for Tuesday, July, 8, 2025 RXST Chart by TradingView RxSight Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$13.20$12.43-5.83%$13.36$12.38864,320 shs$530.31 million07/04/2025$13.20$13.20$13.65$12.82927,254 shs$536.37 million07/03/2025$13.14$13.20+0.45%$13.65$12.82927,254 shs$536.41 million07/02/2025$13.12$13.14+0.15%$13.40$12.93989,005 shs$534.01 million07/01/2025$13.00$13.12+0.92%$13.34$12.77819,502 shs$533.20 million06/30/2025$12.67$13.00+2.60%$13.07$12.69942,652 shs$528.32 million06/27/2025$13.23$12.67-4.23%$13.40$12.601.05 million shs$514.91 million06/26/2025$13.18$13.23+0.38%$13.43$12.95482,474 shs$537.67 million06/25/2025$13.70$13.18-3.80%$13.96$13.17451,626 shs$535.60 million06/24/2025$13.54$13.70+1.18%$14.25$13.25480,850 shs$556.77 million Get the Latest News and Ratings for RXST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$13.61$13.54-0.51%$13.88$13.23579,450 shs$550.27 million06/20/2025$13.87$13.61-1.87%$14.29$13.49653,062 shs$553.07 million06/19/2025$13.87$13.87$14.13$13.51594,609 shs$563.68 million06/18/2025$13.50$13.87+2.74%$14.13$13.51594,609 shs$563.68 million06/17/2025$14.09$13.50-4.19%$14.09$13.41731,327 shs$548.60 million06/16/2025$14.21$14.09-0.84%$14.34$13.89381,466 shs$572.58 million06/13/2025$14.27$14.21-0.42%$14.88$13.80535,197 shs$577.45 million06/12/2025$14.91$14.27-4.29%$14.80$14.14521,061 shs$579.89 million06/11/2025$15.69$14.91-4.97%$15.81$14.78680,870 shs$605.90 million06/10/2025$15.30$15.69+2.55%$16.00$15.41443,124 shs$637.60 million06/09/2025$15.04$15.30+1.73%$15.76$15.08614,809 shs$621.75 million Related Companies NovoCure Stock Price Chart LeMaitre Vascular Stock Price Chart National Vision Stock Price Chart Enovis Stock Price Chart CONMED Stock Price Chart Artivion Stock Price Chart Cadre Stock Price Chart Tandem Diabetes Care Stock Price Chart Establishment Labs Stock Price Chart Liquidia Technologies Stock Price Chart Receive RXST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RXST) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
